Australia's most trusted
source of pharma news
Monday, 16 September 2024
Monday, 16 September 2024
Subscribe
Login
News Headlines
News Headlines
Listen to this story
News
Why this pharma is sitting pretty
Posted 9 February 2024 AM
Winning earlier-than-expected blockbuster status for one of its products in 2023 seems to have set GSK on a roll.
The company's RSV vaccine, Arexvy, launched last year in the US with expectations of high sales, but not so soon. In its third quarter earnings release, GSK predicted sales of Arexvy would be between $1.7 billion and $1.9 billion for the full year. In fact, the vaccine roared to blockbuster status by pulling in $2.4 billion for 2023.
To see the whole article, please login
Posted 9 February 2024 AM
Winning earlier-than-expected blockbuster status for one of its products in 2023 seems to have set GSK on a roll.
The company's RSV vaccine, Arexvy, launched last year in the US with expectations of high sales, but not so soon. In its third quarter earnings release, GSK predicted sales of Arexvy would be between $1.7 billion and $1.9 billion for the full year. In fact, the vaccine roared to blockbuster status by pulling in $2.4 billion for 2023.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (4)
- Brand Manager - Sydney
- Senior Brand Manager - Sydney
- Brand Manager - Sydney
- Senior Brand Manager - Sydney
Sales & Customer Relations (18)
- Customer Service Representative - Mount Waverley
- Hospital Specialist Representative - Sydney
- Customer Service Representative - Sydney
- Customer Service Representative - Frenchs Forest
- Customer Service Representative - Toongabbie
- Salesforce Developer - Sydney
- GP Sales Representative - Women's Health - NSW North - Sydney
- GP Sales Representative - Women's Health - NSW North - Sydney
- Customer Support Representative - Western Australia
- Hospital Specialist Representative - Brisbane
- Hospital Sales Representative - New South Wales
- Hospital Sales Representative - New South Wales
- Specialist Sales Representative - Melbourne
- Hybrid Pharmaceutical Sales Representative - Brisbane
- Territory Manager - Melbourne
- GP Sales Representative - Sydney
- Account Manager - Melbourne
- Customer Care Representative - Blackburn
Clinical & Medical, R&D (10)
- Senior Clinical Research Scientist - Sydney
- Medical Recruitment Consultant - Sydney
- Medical Science Liaison - Oncology - QLD - Brisbane
- Medical Science Liaison - Ophthalmology - Queensland
- Medical Science Liaison - Ophthalmology - Sydney
- Medical Science Liaison - Ophthalmology - Melbourne
- Clinical Trial Network Site Partner - Sydney
- Associate Scientist - Melbourne
- Medical Affairs Manager - APAC - Sydney
- Senior Specialist, Site Inspections and Compliance - Parkville
Regulatory, Pharmacovigilance & QA (5)
- Quality Assurance Associate - Tullamarine
- Director, Operations Quality - Macquarie Park
- Senior Consultant - Regulatory, Quality & Compliance - Australia
- Quality on the Floor Technician - Dallas
- Regulatory Affairs Associate - Sydney
Other (11)
- Warehouse Assistant - North Ryde
- Warehouse Assistant - North Ryde
- MSL - Oncology/Haematology - QLD - Brisbane
- EHS Advisor - Blacktown
- Sterility Assurance Specialist - Dallas
- Drug Safety Controller - Melbourne
- Storeperson - Macquarie Park
- WHS Advisor - Macquarie Park
- Senior Commercial Insights Analyst - Sydney, NSW
- Recruitment Consultant - Sydney
- Practice Manager - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.